NatureNews - Business - nature.com science feeds

Nature - the world's best science and medicine on your desktop

Strange lesions after stem-cell therapy

Unproven treatment results in mysterious masses.

Spanish science spending lockdown

Young researchers and new projects will take brunt of cuts.

The lost legacy of the last great oil spill

Some ecosystems bounced back after the 1979 Ixtoc I oil spill, but research quickly withered.

Start-up model patently flawed

Study shows more US professors go into business as consultants than as inventors.

Journals step up plagiarism policing

Cut-and-paste culture tackled by CrossCheck software.

Food: Inside the hothouses of industry

Feeding the world is going to require the scientific and financial muscle of agricultural biotechnology companies. Natasha Gilbert asks whether they're up to the task.

US biotech firms line up for tax credits

Application process begins for cash to beat the downturn.

Fears over Europe's GM crop plan

A proposal to let nations opt out of growing European-approved GM varieties is under fire from all sides.

Strong medicine for French research

The medical-research adviser to France's president aims to shift power and money to universities.

US seeks solar flair for fuels

Energy department launches initiative to commercialize artificial photosynthesis.

Food: The global farm

With its plentiful sun, water and land, Brazil is quickly surpassing other countries in food production and exports. But can it continue to make agricultural gains without destroying the Amazon? Jeff Tollefson reports from Brazil.

White House stalls oil-slick research

Half-billion-dollar BP fund put on hold.

Human genome at ten: Science after the sequence

The completion of the draft human genome sequence was announced ten years ago. Nature 's survey of life scientists reveals that biology will never be the same again. Declan Butler reports.

Tapping the crowd for technologies

Just how seriously is BP taking its own call for public solutions to the Gulf oil spill?

Consumer gene testing in the hotseat

A week of hearings sows uncertainty for the fledgling consumer genomics industry.